A pilot study to evaluate the efficacy of cerrobend shielding stents in preventing adverse radiotherapeutic effects in buccal carcinoma patients | Zendy

Saumyendra Vikram Singh | Zendy; Karma Yangchen | Zendy; Ramashanker Siddharth | Zendy; RaghuwarD Singh | Zendy; Himanshi Aggarwal | Zendy; Niraj Mishra | Zendy; Shuchi Tripathi | Zendy; Kirti Srivastava | Zendy; Teethraj Verma | Zendy; Pradeep Kumar | Zendy

Open Access

A pilot study to evaluate the efficacy of cerrobend shielding stents in preventing adverse radiotherapeutic effects in buccal carcinoma patients

Author(s) -

Saumyendra Vikram Singh,

Karma Yangchen,

Ramashanker Siddharth,

RaghuwarD Singh,

Himanshi Aggarwal,

Niraj Mishra,

Shuchi Tripathi,

Kirti Srivastava,

Teethraj Verma,

Pradeep Kumar

Publication year - 2016

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.154015

Subject(s) - medicine , mucositis , trismus , radiation therapy , adverse effect , buccal administration , dysphagia , swallowing , carcinoma , surgery , nuclear medicine , radiology , dentistry

Radiation stents made of Lipowitz metal or cerrobend alloy are commonly used to shield uninvolved tissues from electron beams used in therapeutic radiation treatment of head and neck cancers. However, studies investigating the efficacy of cerrobend shielding stent in patients with unilateral buccal carcinoma remain rare.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research